134 reports of this reaction
2.6% of all ETOMIDATE reports
#11 most reported adverse reaction
RENAL INJURY is the #11 most commonly reported adverse reaction for ETOMIDATE, manufactured by Hospira, Inc.. There are 134 FDA adverse event reports linking ETOMIDATE to RENAL INJURY. This represents approximately 2.6% of all 5,192 adverse event reports for this drug.
Patients taking ETOMIDATE who experience renal injury should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RENAL INJURY is a less commonly reported adverse event for ETOMIDATE, but still significant enough to appear in the safety profile.
In addition to renal injury, the following adverse reactions have been reported for ETOMIDATE:
The following drugs have also been linked to renal injury in FDA adverse event reports:
RENAL INJURY has been reported as an adverse event in 134 FDA reports for ETOMIDATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RENAL INJURY accounts for approximately 2.6% of all adverse event reports for ETOMIDATE, making it a notable side effect.
If you experience renal injury while taking ETOMIDATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.